TY  - JOUR 
AU  - Andreu Crespo, M.A.
AU  - Castro Feijoo, Lidia
AU  - Labarta-Aizpún, J.I.
AU  - Peral, C.
AU  - Barrueta, J.A.
AU  - Rubio-Rodríguez, D.
AU  - Rubio-Terres, C.
PY  - 2023
SN  - 1744-8379
UR  - http://hdl.handle.net/20.500.11940/21283
AB  - Objective: To analyze the cost-effectiveness of weekly somatrogon compared to daily growth hormones (GH-d) in the pediatric population of Spain with growth hormone deficiency (GHD). Methods: Markov model with two states (patients with or without GH-d...
LA  - eng
KW  - Male
KW  - Female
KW  - Humans
KW  - Child
KW  - Cost-Benefit Analysis
KW  - Growth Hormone
KW  - Models, Economic
KW  - Spain
KW  - Quality-Adjusted Life Years
TI  - Cost-effectiveness of somatrogon in the Spanish pediatric population with growth hormone deficiency
DO  - 10.1080/14737167.2023.2256473
T2  - Expert Review of Pharmacoeconomics and Outcomes Research
M2  - 1139
KW  - AS Santiago
KW  - IDIS
VL  - 23
ER  -